Since its introduction in October 2010, severe complications from the use of Pradaxa have been reported thousands of times. Worse still, there were more than 500 reported cases of death due to Pradaxa in 2011 alone. Pradaxa’s manufacturer, Boehringer Ingelheim, has claimed that complications are normal for an anticoagulant, but the frequency and severity of Pradaxa’s reported complications and deaths greatly outnumber those of similar drugs.
Doctors, other medical professionals, and patients themselves, continue to report many adverse side effects from the use of Pradaxa. These include:
- Major bleeding
- Kidney failure
- Heart attack
- Gastrointestinal complications
Recent reports show that these severe and dangerous complications are occurring more frequently than indicated in Boehringer Ingelheims’s reported clinical trials. Because of these adverse impacts, the Food and Drug Administration (FDA) and European Medicines Agency have called for additions to Pradaxa’s warning labels and for a review of the reporting and methods used in Boehringer Ingelheim’s clinical trials that lead to Pradaxa’s initial approval by these agencies.
Please contact us to set up a free evaluation to see if our attorneys can represent you or loved one with in your Pradaxa lawsuit.